Development of the calcium plateau following status epilepticus: Role of calcium in epileptogenesis

Expert Review of Neurotherapeutics

Volumn 9, Issue 6, 2009, Pages 813-824

  Nagarkatti, Nisha ^a   Deshpande, Laxmikant S ^b   DeLorenzo, Robert J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired epilepsy; Calcium homeostasis; Epileptogenesis; Hippocampal neuronal culture; Intracellular calcium; Sprague dawley rat; Status epilepticus

Indexed keywords

CALCIUM; CALCIUM BINDING PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BRAIN INJURY; BRAIN TISSUE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONSCIOUSNESS; DISEASE COURSE; DISEASE DURATION; DISEASE MODEL; ELECTROPHYSIOLOGY; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; GENE EXPRESSION; HOMEOSTASIS; HUMAN; MOLECULAR MECHANICS; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; RECURRENT DISEASE; REVIEW; SECOND MESSENGER;

BIOLOGICAL CLOCKS; BRAIN; CALCIUM; CALCIUM SIGNALING; HUMANS; MODELS, NEUROLOGICAL; NERVE NET; STATUS EPILEPTICUS; SYNAPTIC TRANSMISSION;

EID: 67649996733     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.09.21     Document Type: Review

References (91)

1. Delorenzo RJ, Sun DA, Deshpande LS. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol. Ther. 105(3), 229-266 (2005). (Pubitemid 40297893)
2. Willmore LJ. Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 31 (Suppl. 3), S67-S73 (1990).
3. Cavalheiro EA, Leite JP, Bortolotto ZA et al. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 32(6), 778-782 (1991).
4. Lothman EW, Bertram EH 3rd. Epileptogenic effects of status epilepticus. Epilepsia 34(Suppl. 1), S59-S70 (1993).
5. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann. Neurol. 44(6), 908-912 (1998). (Pubitemid 28558252)
6. DeLorenzo RJ, Hauser WA, Towne AR et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46(4), 1029-1035 (1996). (Pubitemid 26134646)
7. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology 40(5 Suppl. 2), 9-13 (1990).
8. Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia 49(Suppl. 9), 63-73 (2008).
9. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J. Clin. Neurophysiol. 12(4), 316-325 (1995).
10. Li JM, Chen L, Zhou B, Zhu Y, Zhou D. Convulsive status epilepticus in adults and adolescents of southwest China: mortality, etiology, and predictors of death. Epilepsy Behav. 14(1), 146-149 (2009).
11. Drislane FW. Presentation, evaluation, and treatment of nonconvulsive status epilepticus. Epilepsy Behav. 1(5), 301-314 (2000).
12. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J. Clin. Neurophysiol. 12(4), 326-342 (1995).
13. Deshpande LS, Lou JK, Mian A et al. Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry. Eur. J. Pharmacol. 583(1), 73-83 (2008).
14. Fisher RS. Animal models of the epilepsies. Brain Res. Brain Res. Rev. 14(3), 245-278 (1989). (Pubitemid 19247337)
15. McNamara JO, Huang YZ, Leonard AS. Molecular signaling mechanisms underlying epileptogenesis. Sci. STKE 2006(356), re12 (2006).
16. Klitgaard H, Matagne A, Vanneste-Goemaere J, Margineanu DG. Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations. Epilepsy Res. 51(1-2), 93-107 (2002). (Pubitemid 35283881)
17. Pitkanen A, Kharatishvili I, Karhunen H et al. Epileptogenesis in experimental models. Epilepsia 48 (Suppl. 2), 13-20 (2007). (Pubitemid 46849999)
18. Cavalheiro EA. The pilocarpine model of epilepsy. Ital. J. Neurol. Sci. 16(1-2), 33-37 (1995).
19. Sombati S, Delorenzo RJ. Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J. Neurophysiol. 73(4), 1706-1711 (1995).
20. Deshpande LS, Lou JK, Mian A et al. In vitro status epilepticus but not spontaneous recurrent seizures cause cell death in cultured hippocampal neurons. Epilepsy Res. 75(2-3), 171-179 (2007). (Pubitemid 47048660)
21. DeGiorgio CM, Tomiyasu U, Gott PS, Treiman DM. Hippocampal pyramidal cell loss in human status epilepticus. Epilepsia 33(1), 23-27 (1992).
22. Sloviter RS. Status epilepticus-induced neuronal injury and network reorganization. Epilepsia 40 (Suppl. 1), S34-S39; discussion S40-S31 (1999). (Pubitemid 29367111)
23. Tsuchida TN, Barkovich AJ, Bollen AW, Hart AP, Ferriero DM. Childhood status epilepticus and excitotoxic neuronal injury. Pediatr. Neurol. 36(4), 253-257 (2007). (Pubitemid 46601350)
24. Pitkanen A. On the way to cure epilepsy. Expert Rev. Neurother. 4(6), 917-920 (2004). (Pubitemid 39482263)
25. Deshpande LS, Sun DA, Sombati S et al. Alterations in neuronal calcium levels are associated with cognitive deficits after traumatic brain injury. Neurosci. Lett. 441(1), 115-119 (2008).
26. 2+ homeostatic mechanisms in hippocampal neurons surviving brain injury. Eur. J. Neurosci. 27(7), 1659-1672 (2008).
27. Sun DA, Sombati S, Blair RE, DeLorenzo RJ. Long-lasting alterations in neuronal calcium homeostasis in an in vitro model of stroke-induced epilepsy. Cell Calcium 35(2), 155-163 (2004). (Pubitemid 38139674)
28. West AE, Chen WG, Dalva MB et al. Calcium regulation of neuronal gene expression. Proc. Natl Acad. Sci. USA 98(20), 11024-11031 (2001). (Pubitemid 32928677)
29. 2+ release. Trends Pharmacol. Sci. 16(10), 356-359 (1995).
30. Malenka RC, Nicoll RA. Long-term potentiation - a decade of progress? Science 285(5435), 1870-1874 (1999). (Pubitemid 129515501)
31. Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7(2), 357-368 (1987). (Pubitemid 17017465)
32. Raza M, Blair RE, Sombati S et al. Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy. Proc. Natl Acad. Sci. USA 101(50), 17522-17527 (2004). (Pubitemid 39657436)
33. Pal S, Sombati S, Limbrick DD Jr, DeLorenzo RJ. In vitro status epilepticus causes sustained elevation of intracellular calcium levels in hippocampal neurons. Brain Res. 851(1-2), 20-31 (1999). (Pubitemid 30038125)
34. Sun DA, Sombati S, Blair RE, DeLorenzo RJ. Calcium-dependent epileptogenesis in an in vitro model of stroke-induced "epilepsy". Epilepsia 43(11), 1296-1305 (2002).
35. Raza M, Pal S, Rafiq A, DeLorenzo RJ. Long-term alteration of calcium homeostatic mechanisms in the pilocarpine model of temporal lobe epilepsy. Brain Res. 903(1-2), 1-12 (2001). (Pubitemid 32904601)
36. 2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc. Natl Acad. Sci. USA 95(24), 14482-14487 (1998). (Pubitemid 28549393)
37. Pal S, Sun D, Limbrick D, Rafiq A, DeLorenzo RJ. Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. Cell Calcium 30(4), 285-296 (2001). (Pubitemid 33014900)
38. Pal S, Limbrick DD Jr, Rafiq A, DeLorenzo RJ. Induction of spontaneous recurrent epileptiform discharges causes long-term changes in intracellular calcium homeostatic mechanisms. Cell Calcium 28(3), 181-193 (2000). (Pubitemid 30806860)
39. Sherwin AL. Neuroactive amino acids in focally epileptic human brain: a review. Neurochem Res. 24(11), 1387-1395 (1999). (Pubitemid 129723675)
40. Liu Z, Stafstrom CE, Sarkisian MR et al. Seizure-induced glutamate release in mature and immature animals: an in vivo microdialysis study. Neuroreport 8(8), 2019-2023 (1997). (Pubitemid 27314327)
41. Smolders I, Khan GM, Manil J, Ebinger G, Michotte Y. NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis. Br. J. Pharmacol. 121(6), 1171-1179 (1997). (Pubitemid 27303587)
42. Meldrum BS. First Alfred Meyer Memorial Lecture. Epileptic brain damage: a consequence and a cause of seizures. Neuropathol. Appl. Neurobiol. 23(3), 185-201; discussion 201-202 (1997).
43. Rice AC, DeLorenzo RJ. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res. 782(1-2), 240-247 (1998). (Pubitemid 28123000)
44. Hort J, Brozek G, Mares P, Langmeier M, Komarek V. Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures. Epilepsia 40(9), 1177-1183 (1999). (Pubitemid 29416385)
45. Prasad A, Williamson JM, Bertram EH. Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus. Ann. Neurol. 51(2), 175-181 (2002). (Pubitemid 34111439)
46. 2+ store in the plasticity of central neurons. Trends Pharmacol. Sci. 27(2), 78-84 (2006). (Pubitemid 43184028)
47. 2+] dynamics. Biol Res, 37(4), 665-674 (2004).
48. Lazarewicz JW, Rybkowski W, Sadowski M et al. N-methyl-D-aspartate receptor-mediated, calcium-induced calcium release in rat dentate gyrus/CA4 in vivo. J. Neurosci. Res. 51(1), 76-84 (1998). (Pubitemid 28063150)
49. Jin W, Sugaya A, Tsuda T, Ohguchi H, Sugaya E. Relationship between large conductance calcium-activated potassium channel and bursting activity. Brain Res. 860(1-2), 21-28 (2000). (Pubitemid 30155834)
50. Nagarkatti N, Deshpande LS, DeLorenzo RJ. Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture. Neurosci. Lett. 436(3), 289-293 (2008).
51. i increase induced by ATP and bradykinin in PC12 cells. J. Pharmacol. Exp. Ther. 313(2), 720-730 (2005). (Pubitemid 40604173)
52. Carter DS, Harrison AJ, Falenski KW, Blair RE, DeLorenzo RJ. Long-term decrease in calbindin-D28K expression in the hippocampus of epileptic rats following pilocarpine-induced status epilepticus. Epilepsy Res. 79(2-3), 213-223 (2008).
53. Magloczky Z, Halasz P, Vajda J, Czirjak S, Freund TF. Loss of calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy. Neuroscience 76(2), 377-385 (1997). (Pubitemid 27008469)
54. 2+ influx because of a loss of calbindin-D(28k) in temporal lobe epilepsy. J. Neurosci. 20(5), 1831-1836 (2000). (Pubitemid 30220380)
55. Baimbridge KG, Miller JJ. Hippocampal calcium-binding protein during commissural kindling-induced epileptogenesis: progressive decline and effects of anticonvulsants. Brain Res. 324(1), 85-90 (1984). (Pubitemid 15179796)
56. Shetty AK, Turner DA. Intracerebroventricular kainic acid administration in adult rat alters hippocampal calbindin and non-phosphorylated neurofilament expression. J. Comp. Neurol. 363(4), 581-599 (1995). (Pubitemid 26028723)
57. Lee S, Williamson J, Lothman EW et al. Early induction of mRNA for calbindin-D28k and BDNF but not NT-3 in rat hippocampus after kainic acid treatment. Brain Res. Mol. Brain Res. 47(1-2), 183-194 (1997). (Pubitemid 27268273)
58. Sonnenberg JL, Frantz GD, Lee S et al. Calcium binding protein (calbindin-D28k) and glutamate decarboxylase gene expression after kindling induced seizures. Brain Res. Mol. Brain Res. 9(3), 179-190 (1991).
59. Lowenstein DH, Gwinn RP, Seren MS, Simon RP, McIntosh TK. Increased expression of mRNA encoding calbindin-D28K, the glucose-regulated proteins, or the 72 kDa heat-shock protein in three models of acute CNS injury. Brain Res. Mol. Brain Res. 22(1-4), 299-308 (1994). (Pubitemid 24063651)
60. DeLorenzo RJ. The calmodulin hypothesis of neurotransmission. Cell Calcium 2(4), 365-385 (1981). (Pubitemid 12226035)
61. 2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneous recurrent epileptiform discharges. Eur. J. Pharmacol. 588(1), 64-71 (2008).
62. 2+/calmodulin-dependent protein kinase in rat brain. J. Neurosci. 5(12), 3270-3277 (1985). (Pubitemid 16182607)
63. Carter DS, Haider SN, Blair RE et al. Altered calcium/calmodulin kinase II activity changes calcium homeostasis that underlies epileptiform activity in hippocampal neurons in culture. J. Pharmacol. Exp. Ther. 319(3), 1021-1031 (2006). (Pubitemid 44776448)
64. Wasterlain CG, Farber DB. Kindling alters the calcium/calmodulin- dependent phosphorylation of synaptic plasma membrane proteins in rat hippocampus. Proc. Natl Acad. Sci. USA 81(4), 1253-1257 (1984). (Pubitemid 14171494)
65. 2+/calmodulin-dependent protein kinase II during prolonged seizure activity and its consequence after the recovery from seizure activity in rats in vivo. Neuroscience 140(3), 981-992 (2006). (Pubitemid 43767449)
66. Singleton MW, Holbert WH 2nd, Ryan ML et al. Age dependence of pilocarpine-induced status epilepticus and inhibition of CaM kinase II activity in the rat. Brain Res. Dev. Brain Res. 156(1), 67-77 (2005).
67. Churn SB, Sombati S, Jakoi ER, Severt L, DeLorenzo RJ. Inhibition of calcium/calmodulin kinase II α subunit expression results in epileptiform activity in cultuted hippocampal neurons. Proc. Natl Acad. Sci. USA 97(10), 5604-5609 (2000). (Pubitemid 30313765)
68. Merrill MA, Chen Y, Strack S, Hell JW. Activity-driven postsynaptic translocation of CaMKII. Trends Pharmacol. Sci. 26(12), 645-653 (2005). (Pubitemid 41636310)
69. 2+/calmodulin- dependent protein kinase II after a brief pentylenetetrazol seizure; potential role in kindling. Epilepsy Res. 58(2-3), 107-117 (2004). (Pubitemid 38553947)
70. 2+ regulatory network in intact cells. Trends Neurosci. 31(1), 8-19 (2008).
71. Ben-Ari Y. Cell death and synaptic reorganizations produced by seizures. Epilepsia 42(Suppl. 3), 5-7 (2001). (Pubitemid 32781373)
72. Morimoto K, Fahnestock M, Racine RJ. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73(1), 1-60 (2004). (Pubitemid 38749090)
73. 2+-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol. Lett. 64-65 Spec. No, 357-364 (1992). (Pubitemid 23018774)
74. Fujikawa DG. Prolonged seizures and cellular injury: understanding the connection. Epilepsy Behav. 7(Suppl. 3), S3-S11 (2005).
75. Holmes GL. Seizure-induced neuronal injury: animal data. Neurology 59(9 Suppl. 5), S3-S6 (2002). (Pubitemid 35285968)
76. Duncan JS. Seizure-induced neuronal injury: human data. Neurology 59(9 Suppl. 5), S15-S20 (2002). (Pubitemid 35285970)
77. Liu RS, Lemieux L, Bell GS et al. Cerebral damage in epilepsy: a population-based longitudinal quantitative MRI study. Epilepsia 46(9), 1482-1494 (2005). (Pubitemid 43919487)
78. Pitkanen A, Nissinen J, Nairismagi J et al. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog. Brain Res. 135, 67-83 (2002). (Pubitemid 35461007)
79. 2+ stores: activation and function. Trends Neurosci. 18(7), 299-306 (1995).
80. Sanchez RM, Dai W, Levada RE, Lippman JJ, Jensen FE. AMPA/kainate receptor-mediated downregulation of GABAetgic synaptic transmission by calcineurin after seizures in the developing rat brain. J. Neurosci. 25(13), 3442-3451 (2005). (Pubitemid 40471352)
81. Deshpande LS, Nagarkatti N, Ziobro JM, Sombati S, Delorenzo RJ. Carisbamate prevents the development and expression of spontaneous recurrent epileptiform discharges and is neuroprotective in cultured hippocampal neurons. Epilepsia 49(10), 1795 - 1802 (2008).
82. Grabenstatter HL, Dudek FE. A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 49(10), 1787-1794 (2008).
83. Deshpande LS, Nagarkatti N, Sombati S, DeLorenzo RJ. The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons. Epilepsy Res. 79(2-3), 158-165 (2008).
84. Pitkanen A, Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav. l4(Suppl. 1), 16-25 (2009).
85. Pisani A, Bonsi P, Martella G et al. Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Epilepsia 45(7), 719-728 (2004). (Pubitemid 38890968)
86. Kulak W, Sobaniec W, Wojtal K, Czuczwar SJ. Calcium modulation in epilepsy. Pol. J. Pharmacol. 56(1), 29-41 (2004). (Pubitemid 38515283)
87. Brandt C, Potschka H, Loscher W, Ebert U. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118(3), 727-740 (2003). (Pubitemid 36506960)
88. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50(1-2), 105-123 (2002). (Pubitemid 34876591)
89. Rogawski MA, Wenk GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Rev. 9(3), 275-308 (2003). (Pubitemid 37254706)
90. Rice AC, DeLorenzo RJ. N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam. Neuroscience 93(1), 117-123 (1999). (Pubitemid 29290692)
91. Internet Stroke Center at Washington Univ. in St. Louis. The Stroke Trials Registry www.strokecenter.org/trials/InterventionDetail.aspx?tid=95